MarketCapExport financials
New Frontier Health Corporation (NFH)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
TelegramNew Frontier Health Corporation Financial Ratios 2020-2011 | NFH
Brief overview of New Frontier Health Corporation's valuation and returns
The review covers five available annual periods spanning 2018 to 2020.
Key multiples at the end of the period are EV/EBITDA 7.16x (median 7.16x), P/S 3.25x (median 3.25x), P/B 0.94x (median 0.98x). The multiple basket looks neutral against its history, differing from median levels by roughly 0%.
The latest available business-quality ratios are ROE -5%, ROA -2.9%, ROCE -0.6%. Losses and negative capital returns make ordinary P/E-like references unstable or inapplicable.
The PEG ratio is 9.2x; investors pay a high price per unit of expected growth.
The cash cycle accelerated by 301.5 days to -288.2 days. Less capital is tied up in operations.
Valuation takeaway
New Frontier Health Corporation trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.
Annual Financial Ratios New Frontier Health Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-18.7 | -40.0 | -20.0 | - | - | - | - | - | - | - |
P/S |
3.2 | 3.4 | 1.3 | - | - | - | - | - | - | - |
EV/EBITDA |
7.2 | 7.3 | 4.8 | - | - | - | - | - | - | - |
PEG |
9.2 | 8.03 | 0.05 | - | - | - | - | - | - | - |
P/B |
0.9 | 1.0 | 1.3 | - | - | - | - | - | - | - |
P/CF |
4.2 | -48.8 | -1.0 | - | - | - | - | - | - | - |
ROE % |
-5.01 | -2.45 | -6.62 | - | - | - | - | - | - | - |
ROA % |
-2.93 | -1.37 | -6.45 | - | - | - | - | - | - | - |
ROCE % |
-0.57 | -0.08 | -2.98 | - | - | - | - | - | - | - |
DSO |
37.0 | 43.5 | - | - | - | - | - | - | - | - |
DIO |
80.1 | 54.1 | - | - | - | - | - | - | - | - |
DPO |
77.3 | 94.7 | 2.6 | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company New Frontier Health Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Russia
USA
China
Germany
Britain
